Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1

NCT00032929 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

269

Enrollment

NIH

Sponsor class

Conditions

Cocaine-Related Disorders

Interventions

DRUG: Selegiline

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]